Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cartistem vs Microfracture in Knee Cartilage Injury
NCT01041001Phase 3Completed
- Sponsor
- MEDIPOST
- Start
- Feb 2009
- Primary completion
- Dec 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of Cartistem in knee articular cartilage defect (ACD), osteoarthritis (OA), sponsored by MEDIPOST. Started Feb 2009; status: completed.
02
Drugs
Cartistem
03
Conditions
knee articular cartilage defect (ACD)osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01041001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01041001.